TrialJournal of comparative effectiveness research2024

Efficacy of CARVYKTI in CARTITUDE-4 versus other conventional treatment regimens for lenalidomide-refractory multiple myeloma using inverse probability of treatment weighting.

Winfried Alsdorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.